RTW INVESTMENTS, LP bought KLRA
April 20, 2026 · Form 4 insider transaction
RTW INVESTMENTS, LP bought 500,000 shares of Kailera Therapeutics, Inc. at $16.00 per share, a transaction worth $8.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
500,000
Price
$16.00
Total value
$8.00M
InsiderRTW INVESTMENTS, LP
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 20, 2026
Filing dateApril 22, 2026
Shares owned after10,776,820
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Held by certain affiliated funds managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein.